Month: September 2015

PABIC Join Hands With ICCBS for Youth Internship Program 2015

  • September 18, 2015
The Pakistan Biotechnology Information Center (PABIC), is actively working as a resource based information center in Pakistan, to design educational approaches, to train interdisciplinary scientist in emerging area of health, agriculture, bioinformatics and environmental biotechnology. To promote the understanding of the biotechnology and biological sciences among the Youth of Pakistan, the PABIC announces the internship […]
Read More

Biotech research in public sector of Pakistan

  • September 17, 2015
Globally, the role of the public sector in the research and development of agricultural biotechnology, particularly in developing countries, is very important because ultimately R&D improves the food supply and nutrition, creates jobs and increases farmers’ incomes – the common goals of countries like Pakistan where demand for food, feed and fiber crops is increasing […]
Read More

Dietary revolution in the offing

  • September 17, 2015
After scientists’ thumping YES to the anti-biotechnology campaigners’ question ‘Is genetically food safe to eat?’, the world hasn’t looked back and the global biotech research in food crops has entered a new era in both developed and developing countries. Today, the revolutionary science of biotechnology is one of the biggest hopes for the world in […]
Read More

U.S.-Pakistan wheat breeders’ cooperation develops unique pool of wheat genetics to fight wheat diseases

  • September 14, 2015
On Tuesday, 8th September, 2015; The Annual Wheat Planning and Wheat Productivity Enhancement Programme (WPEP) meeting held at National Agricultural Research Center (NARC).  The Wheat Productivity Enhancement Project (WPEP) has primary goal to protect and enhance the productivity of wheat in Pakistan, with particular attention to wheat rusts, which are difficult and expensive to treat with […]
Read More

Leishmaniasis can be treated with Selective Ribosome-Targeting Drug with Low Ototoxicity

  • September 3, 2015
In the new study, a team of researchers, led by Timor Baasov, professor at the Technion – Israel Institute of Technology (Haifa, Israel), investigated the structural basis for the targeting of leishmanial ribosomes by AGs and performed comparative testing of the potential clinical effectiveness and side-effects of new (semi-) synthetic derivatives of aminoglycoside paromomycin (PAR). In […]
Read More